Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2012 August;64(4) > Minerva Ginecologica 2012 August;64(4):337-44

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  


Minerva Ginecologica 2012 August;64(4):337-44

language: Italian

Hormone replacement therapy and urogenital disease in postmenopausal women

Della Martina M., Xodo S., Vogrig E., Rinuncini D., Ganzitti L., Driul L., Fabiani G., Marchesoni D.

Clinica di Ostetricia e Ginecologia, Azienda Ospedaliero Universitaria di Udine Udine, Italia


PDF  


Estrogen deficit in postmenopausal women causes urogenital atrophy, which is responsible for a wide range of urinary disorders (urinary incontinence, urge incontinence, recurrent urinary infections) and genital disorders (prolapse, dispareunya, vaginal dryness). The efficacy of estrogen therapy on urinary incontinence is not yet demonstrated, but it is widely recognized that the topical use of estrogens lowers the risk of recurrent urinary infections and improves urogenital atrophy.

top of page

Publication History

Cite this article as

Corresponding author e-mail

m.dellamartina@libero.it